ADVERT: Patients have to trust that if I were in their shoes, I wouldn’t do anything differently.

63

SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System

Drug Eluting stent technology with durable polymer has shown encouraging efficacy compared to bare metal stents, significantly reducing restenosis and revascularization procedures. Still there remains a concern with long-term durable polymer exposure.

What if there was a technology that offered the benefits of being able to improve the ability to acutely treat patients, improve the vessel’s ability to heal, and free patients from long-term polymer exposure?

Introducing the SYNERGY Stent

Designed to help patients heal from day one and beyond

LEAVE A REPLY